Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRAIL, Inc. stock logo
GRAL
GRAIL
$70.54
+11.2%		$66.68
$29.95
▼
$118.84
$3.03B3.22939,711 shs321,449 shs
Insulet Corporation stock logo
PODD
Insulet
$164.93
-3.3%		$154.87
$138.79
▼
$354.88
$11.40B1.111.25 million shs695,511 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$74.82
-4.1%		$72.26
$60.10
▼
$156.00
$2.58B1.891.07 million shs588,289 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRAIL, Inc. stock logo
GRAL
GRAIL
-1.52%-10.22%-7.24%+16.45%+85.93%
Insulet Corporation stock logo
PODD
Insulet
+1.88%+7.36%+8.17%-0.88%-41.47%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
+2.24%+9.55%+15.92%-22.61%-25.59%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GRAIL, Inc. stock logo
GRAL
GRAIL
$70.54
+11.2%		$66.68
$29.95
▼
$118.84
$3.03B3.22939,711 shs321,449 shs
Insulet Corporation stock logo
PODD
Insulet
$164.93
-3.3%		$154.87
$138.79
▼
$354.88
$11.40B1.111.25 million shs695,511 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$74.82
-4.1%		$72.26
$60.10
▼
$156.00
$2.58B1.891.07 million shs588,289 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GRAIL, Inc. stock logo
GRAL
GRAIL
-1.52%-10.22%-7.24%+16.45%+85.93%
Insulet Corporation stock logo
PODD
Insulet
+1.88%+7.36%+8.17%-0.88%-41.47%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
+2.24%+9.55%+15.92%-22.61%-25.59%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GRAIL, Inc. stock logo
GRAL
GRAIL
2.30
Hold$67.78-3.91% Downside
Insulet Corporation stock logo
PODD
Insulet
2.68
Moderate Buy$233.3841.50% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.38
Hold$129.5573.15% Upside

Current Analyst Ratings Breakdown

Latest GRAL, TMDX, and PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/28/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C) ➝ Hold (C-)
7/28/2026
Insulet Corporation stock logo
PODD
Insulet
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Neutral$174.00
7/28/2026
Insulet Corporation stock logo
PODD
Insulet
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy ➝ Neutral$174.00
7/28/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$80.00
7/22/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
7/17/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/15/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/15/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$58.00 ➝ $65.00
7/13/2026
Insulet Corporation stock logo
PODD
Insulet
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$219.00 ➝ $210.00
7/13/2026
Insulet Corporation stock logo
PODD
Insulet
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$280.00 ➝ $245.00
7/10/2026
Insulet Corporation stock logo
PODD
Insulet
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$250.00 ➝ $225.00
(Data available from 7/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GRAIL, Inc. stock logo
GRAL
GRAIL
$147.17M20.57N/AN/A$66.13 per share1.07
Insulet Corporation stock logo
PODD
Insulet
$2.71B4.22$6.23 per share26.49$21.54 per share7.66
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$605.49M4.27$3.85 per share19.43$13.79 per share5.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GRAIL, Inc. stock logo
GRAL
GRAIL
-$408.35M-$10.37N/AN/AN/A-253.22%-16.42%-14.34%8/11/2026 (Estimated)
Insulet Corporation stock logo
PODD
Insulet
$247.10M$4.3038.2820.641.1710.44%26.87%12.01%8/5/2026 (Confirmed)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$4.4016.9923.09N/A27.04%22.38%8.46%8/4/2026 (Estimated)

Latest GRAL, TMDX, and PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
GRAIL, Inc. stock logo
GRAL
GRAIL
-$2.6556N/AN/AN/A$42.39 millionN/A
8/5/2026Q2 2026
Insulet Corporation stock logo
PODD
Insulet
$1.45N/AN/AN/A$787.39 millionN/A
8/4/2026Q2 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.50N/AN/AN/A$183.79 millionN/A
5/6/2026Q1 2026
Insulet Corporation stock logo
PODD
Insulet
$1.19$1.42+$0.23$1.30$729.89 million$761.70 million
5/5/2026Q1 2026
GRAIL, Inc. stock logo
GRAL
GRAIL
-$2.7629-$2.29+$0.4729-$2.29$39.16 million$40.79 million
5/5/2026Q1 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.62$0.30-$0.32$0.20$174.44 million$173.93 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GRAIL, Inc. stock logo
GRAL
GRAIL
N/AN/AN/AN/AN/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
11.74
11.74
Insulet Corporation stock logo
PODD
Insulet
0.71
2.49
1.81
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.70
6.74
6.19

Institutional Ownership

CompanyInstitutional Ownership
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
Insulet Corporation stock logo
PODD
Insulet
N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
GRAIL, Inc. stock logo
GRAL
GRAIL
1.83%
Insulet Corporation stock logo
PODD
Insulet
0.36%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
GRAIL, Inc. stock logo
GRAL
GRAIL
1,36042.92 million42.13 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
5,40069.26 million69.02 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21034.56 million32.18 millionOptionable

Recent News About These Companies

TransMedics Group (NASDAQ:TMDX) Coverage Initiated at UBS Group
July 30 at 2:18 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30929586
Bank of New York Mellon Corp Has $21.01 Million Position in TransMedics Group, Inc. $TMDX
July 29 at 3:27 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-has-2101-million-position-in-transmedics-group-inc-tmdx-2026-07-29/
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
July 28 at 4:29 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/transmedics-to-present-at-the-canaccord-genuity-46th-annual-growth-conference-302836981.html
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for
July 28 at 11:06 AM  |  zacks.comhttps://www.zacks.com/stock/news/2962084/analysts-estimate-transmedics-tmdx-to-report-a-decline-in-earnings-what-to-look-out-for?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_9-2962084
TransMedics Group (NASDAQ:TMDX) Coverage Initiated by Analysts at UBS Group
July 28 at 9:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/transmedics-group-nasdaqtmdx-coverage-initiated-by-analysts-at-ubs-group-2026-07-28/
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
July 24, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-transmedics-group-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302834266.html
Militia Capital Management LLC Acquires New Shares in TransMedics Group, Inc. $TMDX
July 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-militia-capital-management-llc-acquires-new-shares-in-transmedics-group-inc-tmdx-2026-07-23/
TransMedics Group (TMDX) Projected to Post Earnings on Thursday
July 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/transmedics-group-tmdx-projected-to-post-earnings-on-thursday-2026-07-23/
Fifth Third Bancorp Has $2.07 Million Position in TransMedics Group, Inc. $TMDX
July 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-fifth-third-bancorp-has-207-million-position-in-transmedics-group-inc-tmdx-2026-07-22/
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Hold" by Brokerages
July 22, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30913610
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of "Hold" by Brokerages
July 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/transmedics-group-inc-nasdaqtmdx-given-average-recommendation-of-hold-by-brokerages-2026-07-22/
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
July 21, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/transmedics-to-report-second-quarter-2026-financial-results-on-august-4-2026-302831235.html
Principal Financial Group Inc. Has $23.01 Million Stock Holdings in TransMedics Group, Inc. $TMDX
July 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-principal-financial-group-inc-has-2301-million-stock-holdings-in-transmedics-group-inc-tmdx-2026-07-21/
Geneos Wealth Management Inc. Makes New Investment in TransMedics Group, Inc. $TMDX
July 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-geneos-wealth-management-inc-makes-new-investment-in-transmedics-group-inc-tmdx-2026-07-18/
Regency Capital Management Inc. DE Purchases Shares of 21,846 TransMedics Group, Inc. $TMDX
July 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-regency-capital-management-inc-de-purchases-shares-of-21846-transmedics-group-inc-tmdx-2026-07-16/
TransMedics Group (NASDAQ:TMDX) Shares Up 6.3% - Time to Buy?
July 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/transmedics-group-nasdaqtmdx-shares-up-63-time-to-buy-2026-07-13/
Candriam S.C.A. Buys 49,580 Shares of TransMedics Group, Inc. $TMDX
July 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-candriam-sca-buys-49580-shares-of-transmedics-group-inc-tmdx-2026-07-12/
Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?
July 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/transmedics-group-inc-tmdx-stock-145053504.html
Analysts Offer Insights on Healthcare Companies: Daiichi Sankyo Company (OtherDSKYF), Vertex Pharmaceuticals (VRTX) and TransMedics Group (TMDX)
July 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX-Q/pressreleases/3181878/analysts-offer-insights-on-healthcare-companies-daiichi-sankyo-company-otherdskyf-vertex-pharmaceuticals-vrtx-and-transmedics-group-tmdx/
TransMedics Completes PAD Aviation Investment to Expand in Europe
July 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2949650/transmedics-completes-pad-aviation-investment-to-expand-in-europe?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2949650
TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH
July 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/transmedics-group-announces-completion-of-strategic-investment-in-pad-aviation-service-gmbh-302818049.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRAIL stock logo

GRAIL NASDAQ:GRAL

$70.70 +7.26 (+11.44%)
As of 03:40 PM Eastern
This is a fair market value price provided by Massive. Learn more.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Insulet stock logo

Insulet NASDAQ:PODD

$164.93 -5.69 (-3.33%)
As of 03:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$74.82 -3.19 (-4.08%)
As of 03:40 PM Eastern
This is a fair market value price provided by Massive. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas